- Preview Available
- Scholarly Journal
Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial
Nature Communications; London Vol. 16, Iss. 1, (2025): 3143.
DOI:10.1038/s41467-025-58435-9
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.